VM-105

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVM-105
Drug Alias Nameadenosine deaminase gene therapy (ADA-SCID), retroviral vector (ViroMed/Genethon)VM-105
ClassificationBiologics
Mechanisms of ActionADA gene transference
TargetsAdenosine deaminase
Therapy Area/IndicationsAdenosine deaminase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceSouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelixmith Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGénéthonHelixmith Co Ltd
Active IndicationsN/A
Inactive IndicationsAdenosine deaminase deficiency

Other Information

ATC CodeN/A
Related LinksN/A